CVS Health announced on Thursday that it had achieved $1 billion in net income for the second quarter of the year. This milestone comes as the company works to address the high health benefit costs that have been impacting its Aetna health insurance business as well as other competitors in the industry.
Despite still having a relatively high medical benefit ratio, which measures the percentage of premium revenue spent on medical costs, CVS Health saw a slight increase to 89.9% in the second quarter compared to 89.6% in the same period last year. For the first six months of the year, the medical benefit ratio was 88.6%, an improvement from 90% in the previous year.
Brian Newman, the CFO of CVS Health, expressed optimism about the company’s performance, stating, “We are encouraged by a second consecutive quarter of solid results while navigating a dynamic environment.”
In terms of financial figures, CVS reported a net income of $1.02 billion, or 80 cents per share, down from $1.77 billion, or $1.41 per share, in the second quarter of the previous year. The decrease in net income was attributed to litigation charges, including penalties against the company’s Omnicare long-term care pharmacy for false claims.
Adjusted earnings per share remained relatively consistent at $1.81 compared to $1.83 in the prior year. CVS highlighted improved operating performance in its Health Care Benefits and Pharmacy & Consumer Wellness segments, offset by a decline in the Health Services segment.
The company, which serves over 26 million members through its Aetna brand health insurance plans, reported a decrease in total membership by 358,000 due to announced declines in the individual exchange product line. CVS also announced plans to exit the individual business under the Affordable Care Act starting in the 2026 benefit year.
Total revenues in the health care benefits segment increased by 11.6% to nearly $36.3 billion, driven by growth in the Government business, particularly due to the Inflation Reduction Act’s impact on the Medicare Part D program. Adjusted operating income for this segment increased by 39.4% to $1.3 billion compared to the previous year.
Overall, CVS reported a total company revenue increase of 8.4% to $98.9 billion, driven by revenue growth across all operating segments. The company emphasized its commitment to providing a connected and simplified health care experience for the 185 million individuals it serves.
In the pharmacy and wellness segment, total revenues increased by 12.5% to $33.58 billion, primarily driven by pharmacy drug mix and increased prescription and front store volume. Adjusted operating income for this segment increased by 7.6% to $1.33 billion compared to the previous year.
CVS Health’s strong financial performance reflects its focus on operational and financial improvement across its various businesses, including Aetna, CVS Caremark, and CVS Pharmacy. The company continues to prioritize delivering better access, affordability, and advocacy in the healthcare industry.
